Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04843371 · ClinicalTrials.gov registry record
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
A clinical trial of Cardiomyopathies and Valvular Heart Disease, sponsored by Tulane University.
- Recruiting
- Registry status
- 500
- Enrollment target
- 3
- Study locations
NCT04843371 is a study of Cardiomyopathies and Valvular Heart Disease that is actively recruiting participants, run by Tulane University. The registered enrollment target is 500 participants, below the 606-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (17% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04843371, a study of Cardiomyopathies and Valvular Heart Disease, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population. Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Photoplethysmography
Study Locations (3)
Louisiana
- East Jefferson General Hospital - New Orleans
- University Medical Center - New Orleans
- Tulane Doctors - Speciality Care - Napoleon - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-08-20 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04843371
The ClinicalTrials.gov registry entry for NCT04843371 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 606-participant average among 17 other Cardiomyopathies trials with a reported enrollment target (17% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cardiomyopathies appearing as the primary indexed condition, and to 1 intervention - of which Photoplethysmography is the first listed.
NCT04843371 reports 3 study locations spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT04843371 about?
NCT04843371 is a clinical study titled "PPG to Predict Ejection Fraction and Other Echographic Data in the General Population". The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signal...
What is the current status of trial NCT04843371?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2021-08-20. Estimated completion is 2026-12.
What conditions does trial NCT04843371 study?
This clinical trial studies the following conditions: Cardiomyopathies, Valvular Heart Disease, Pericardial Disease.
What interventions are being tested in trial NCT04843371?
The interventions under investigation include: Photoplethysmography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04843371?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04843371 being conducted?
This trial has 3 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
RECRUITING · Phase 1
-
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
RECRUITING · Phase 4
-
PKP2-ACM Natural History Study
RECRUITING
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
-
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.